Privia Health Group, Inc. (PRVA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch PRVA
See up to 3 months of PRVA. The 7-day demo opens the 1M and 3M ranges and puts PRVA on your watchlist.
Start 7-day demoLatest PRVA insider trades
About Privia Health Group, Inc. (PRVA)
Privia Health Group, Inc. files with the SEC under CIK 0001759655 and is classified as health services. We track it alongside the rest of the Health Care sector.
PRVA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 6,350 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PRVA insider transactions (Form 4)
3339 Form 4 filings on record, the earliest from May 21, 2025, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 5,177 | $23.15 | $120K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 5,829 | $22.84 | $133K | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 7,788 | $2.00 | $16K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 7,788 | $24.99 footnote F2 | $195K | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 16,550 | $2.00 | $33K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 16,550 | $25.00 footnote F3 | $414K | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 7,788 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 16,550 | $0.00 | - | |
| ||||||
| David Mountcastle - Officer | Option exercise | Common Stock, par value $0.01 per share | 5,361 | $2.00 | $11K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 5,361 | $25.00 footnote F2 | $134K | |
| David Mountcastle - Officer | Option exercise | Common Stock, par value $0.01 per share | 7,697 | $2.00 | $15K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 7,697 | $25.05 footnote F3 | $193K | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 1,668 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 1,100 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 1,893 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 700 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 998 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 2,699 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 3,428 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 572 | $0.00 | - | |
| ||||||
| David Mountcastle - Officer | Option exercise | Common Stock, par value $0.01 per share | 23,887 | $2.00 | $48K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 23,887 | $25.03 footnote F2 | $598K | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 7,698 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 4,792 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 3,430 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 7,967 | $0.00 | - | |
| ||||||
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 13,647 | $2.00 | $27K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 13,647 | $25.01 footnote F2 | $341K | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 13,647 | $0.00 | - | |
| ||||||
| Lance Berberian - Director | Grant or award | Common Stock, $0.01 par value per share | 7,668 | $0.00 | - | |
| David P. King - Director | Grant or award | Common Stock, $0.01 par value per share | 8,396 | $0.00 | - | |
| David S. Wichmann - Director | Grant or award | Common Stock, par value $0.01 per share | 8,396 | $0.00 | - | |
| Nancy G. Cocozza - Director | Grant or award | Common Stock, $0.01 par value per share | 8,396 | $0.00 | - | |
Item 5.02, 9.01
Item 2.02, 9.01
Item 5.02
Item 5.07
Recent PRVA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
PRVA insider trading FAQ
What is the latest insider trade for PRVA?
Privia Health Group, Inc. (PRVA) had 1 insider filing in the last 90 days, with the most recent on 2026-09-03. The full record for PRVA runs to 39 Form 4 filings, the earliest from 2025-05-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PRVA stock?
No insider purchases of PRVA were filed in the last 90 days.
How many insiders are selling PRVA stock?
No insider sales of PRVA were filed in the last 90 days. 40 sales are on record for this company.
Where can I see PRVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PRVA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Opella Finley Ernest view on EDGAR
- - David Mountcastle view on EDGAR
- - David Mountcastle view on EDGAR
- - Matthew Shawn Morris view on EDGAR
- - David Mountcastle view on EDGAR
- - Matthew Shawn Morris view on EDGAR
- - Matthew Shawn Morris view on EDGAR
- - David Mountcastle view on EDGAR
- - Francis S. Soistman Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PRVA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PRVA with a 7-day demo
- PRVA on your watchlist
- Every PRVA Form 4 filing on record
- Up to 3 months of PRVA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
